Genscript Biotech's (HKG:1548) Nasdaq-listed associate Legend Biotech reported a loss of $125.3 million for the third quarter, a twofold increase from $62.2 million a year ago.
Loss per share was $0.34, compared with $0.17 a year earlier, according to a Wednesday filing with the Hong Kong bourse.
Total revenue for the quarter was $160.2 million, compared with $96 million in the year-ago period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments